Duhamel, M., Rose, M., Rodet, F., Murgoci, A. N., Zografidou, L., Régnier-Vigouroux, A., . . . Salzet, M. (2018). Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies. Mol Cell Proteomics.
Citação norma ChicagoDuhamel, Marie, et al. "Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages Is a Promising Antiglioma Strategy As Revealed By Proteomics and Cytotoxicity Studies." Mol Cell Proteomics 2018.
Citação norma MLADuhamel, Marie, et al. "Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages Is a Promising Antiglioma Strategy As Revealed By Proteomics and Cytotoxicity Studies." Mol Cell Proteomics 2018.